Rivotril is one of the trademarks under which clonazepam is marketed, an active principle that belongs to the benzodiazepine family.
This medicine acts on the central nervous system to combat, mainly, seizures, anxiety states and clinical pictures that present alterations in mood.
Rivotril is also effective in preventing absences, Lennox-Gastaut syndrome, akinetic and myoclonus seizures, as well as myoclonus that occurs at night. However, it is not effective for the treatment of generalized tonic-clonic seizures.
Thus, Rivotril is indicated when patients have not responded to other treatments for myoclonic seizures.
The first benzodiazepine was discovered in 1949 by the scientist Leo Sternbach and was later synthesized by Roche laboratories in 1955. This same laboratory is the same one that synthesized clonazepam 30 years later.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy